Pexidartinib

In this Healio interview, Sandra D’Angelo, MD, discussed two “interesting” studies for pigmented villonodular synovitis, or PVNS, presented at the Connective Tissue Oncology Society Annual Meeting.

A reduced dosage and updated regimen are now available for the oral small molecule pexidartinib in the treatment of adults with symptomatic tenosynovial giant cell tumor, according to a press release from the drug manufacturer.